The winter solstice, once celebrated for its promise of steadily longer days, brought sunny news for Esperion Therapeutics Inc. this year in the form of a $1.3 billion buyout by Pfizer Inc. - at $35 per share, a 54 percent premium to the company's average closing share price during the previous 20 days. (BioWorld Today) Read More
BioWorld's offices will be closed Wednesday, Dec. 24, through Friday, Dec. 26, in observance of the Christmas holiday. No issues will be published those days. The next issue of BioWorld Today will be published Monday, Dec. 29. Read More
